CIK 0001787297 · Non-accelerated filer<br>Smaller reporting company
Passage BIO, Inc.
Sign in to watch- Ticker
- PASG
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 822729751
- Phone
- 2678660312
- Business address
- ONE COMMERCE SQUARE, 2005 MARKET STREET, 39TH FLOOR, PHILADELPHIA, PA, 19103
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-25 | Lynx1 Capital Management LP 10% owner | Purchase | +50,055 | $4.12 | $206K | 673,759 |
| 2026-05-19 | Sondhi Dolan Director | Grant or award · Director Stock Option (right to buy) | +10,539 | 10,539 | ||
| 2026-05-19 | Porter Derrell Director | Grant or award · Director Stock Option (right to buy) | +10,539 | 10,539 | ||
| 2026-05-19 | Kapadia Sandip Director | Grant or award · Director Stock Option (right to buy) | +10,539 | 10,539 | ||
| 2026-05-19 | Countouriotis Athena Director | Grant or award · Director Stock Option (right to buy) | +10,539 | 10,539 | ||
| 2026-05-19 | Kassberg Thomas Richard Director | Grant or award · Director Stock Option (right to buy) | +10,539 | 10,539 | ||
| 2026-05-19 | GOWEN MAXINE Director | Grant or award · Director Stock Option (right to buy) | +10,539 | 10,539 | ||
| 2026-03-16 | Borthwick Kathleen CFO | Grant or award · Employee Stock Option (right to buy) | +15,610 | 15,610 | ||
| 2026-03-16 | Chou William PRESIDENT AND CEO | Grant or award · Employee Stock Option (right to buy) | +58,000 | 58,000 | ||
| 2026-01-08 | Borthwick Kathleen CFO | Option exercise | +5,000 | 7,464 | ||
| 2026-01-08 | Borthwick Kathleen CFO | Sale | −2,062 | $18.44 | $38K | 5,402 |
| 2026-01-08 | Borthwick Kathleen CFO | Option exercise · Restricted Stock Unit | −5,000 | 5,000 | ||
| 2026-01-08 | Chou William PRESIDENT AND CEO | Option exercise | +10,000 | 10,600 | ||
| 2026-01-08 | Chou William PRESIDENT AND CEO | Sale | −4,076 | $18.44 | $75K | 6,524 |
| 2026-01-08 | Chou William PRESIDENT AND CEO | Option exercise · Restricted Stock Unit | −10,000 | 10,000 | ||
| 2025-09-15 | Lynx1 Capital Management LP 10% owner | Purchase | +11,900 | $6.99 | $83K | 623,704 |
| 2025-09-12 | Lynx1 Capital Management LP 10% owner | Purchase | +19,783 | $6.99 | $138K | 611,804 |
| 2025-09-11 | Lynx1 Capital Management LP 10% owner | Purchase | +325 | $6.96 | $2K | 592,021 |
| 2025-07-24 | Lynx1 Capital Management LP 10% owner | Purchase | +66,423 | $5.71 | $379K | 591,696 |
| 2025-07-23 | Lynx1 Capital Management LP 10% owner | Purchase | +49,302 | $5.74 | $283K | 525,273 |
Page 1 of 8 · 152 trades